The proposed bill, if enacted, would amend current statutes regarding the coverage of diabetes-related equipment and supplies by accountable health plans. Specifically, it would add new items to the list of covered supplies, including insulin pens, self-injectable medications for controlling glucose levels, adjunctive and nonadjunctive continuous glucose monitors and relevant equipment or supplies, and insulin pumps, including automated insulin delivery systems and continuous subcutaneous insulin infusion devices. Additionally, it would make technical and conforming changes to the existing language. The bill would also modify existing provisions by deleting certain terms and updating the language to clarify coverage requirements. For instance, it would replace agents with self-injectable medications and change sugar to glucose levels. Furthermore, it would ensure that the coverage for diabetes supplies is medically necessary and prescribed, while also allowing accountable health plans to impose cost-sharing measures for these benefits. Overall, the bill aims to enhance the scope of diabetes care covered by health plans, ensuring that patients have access to essential monitoring and treatment tools.

Statutes affected:
Introduced Version: 20-2325
House Engrossed Version: 20-2325